One of the key requirements of the new pharmacovigilance legislation (Regulation 726/2004) in the EU is simplified reporting of individual case safety reports (ICSRs) by a Marketing Authorization Holder (MAH) to the new EudraVigilance (EV) system

Share on LinkedIn

Related Posts

Webinar: The Rise of Agentic PV: AI that thinks, plans, and acts

Learn how Agentic AI is bringing a new era of innovation to pharmacovigilance.

Experience LifeSphere in Action

Unlock the full potential of your organization with LifeSphere.